Busulfan Injection

DRUG2 trials

Sponsors

Institut Paoli-Calmettes, Ruijin Hospital

Conditions

AML, AdultAcute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm

Phase 2

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Not yet recruitingNCT04451200

Institut Paoli-CalmettesAcute Leukemia, Mielodysplasic Syndrome, Myeloproliferative Neoplasm

Start: 2020-11-30End: 2028-12-31Target: 82Updated: 2020-11-17

Phase 3

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Not yet recruitingNCT06297772

Ruijin HospitalAML, Adult

Start: 2024-06-01End: 2028-05-01Target: 220Updated: 2024-06-04